Viveash Dawn 4
4 · Orexigen Therapeutics, Inc. · Filed Mar 4, 2011
Insider Transaction Report
Form 4
Viveash Dawn
Head of Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2011-03-02+35,000→ 35,000 totalExercise: $2.94Exp: 2021-01-18→ Common Stock (35,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2011-03-02−45,000→ 0 totalExercise: $5.89Exp: 2020-09-19→ Common Stock (45,000 underlying) - Award
Employee Stock Option (right to buy)
2011-03-02+45,000→ 45,000 totalExercise: $2.94Exp: 2020-09-19→ Common Stock (45,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2011-03-02−35,000→ 0 totalExercise: $9.31Exp: 2021-01-18→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on September 20, 2010 and provides that 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following January 18, 2011, so that all of the shares of the stock subject to the option shall be vested on January 18, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not Applicable
- [F3]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 18, 2011 and provides that 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following January 18, 2011, so that all of the shares of the stock subject to the option shall be vested on January 18, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.